Showing results (331-340 of 340) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 340 results.
Diabetes|June 19, 2015
Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 DiabetesJustin M Gregory, Guillaume Kraft, Melanie F Scott, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Human glucagon receptor antagonists based on alkylidene hydrazidesAnthony Ling, Michael Plewe, Javier Gonzalez, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2007
Impacts of Hurricanes Katrina and Rita on the microbial landscape of the New Orleans areaC D Sinigalliano, M L Gidley, T Shibata, et al.
Journal of Medicinal Chemistry|February 8, 2002
Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activityPer Sauerberg, Ingrid Pettersson, Lone Jeppesen, et al.
Journal of Medicinal Chemistry|December 13, 2002
Optimization of alkylidene hydrazide based human glucagon receptor antagonists. Discovery of the highly potent and orally available 3-cyano-4-hydroxybenzoic acid [1-(2,3,5,6-tetramethylbenzyl)-1H-indol-4-ylmethylene]hydrazidePeter Madsen, Anthony Ling, Michael Plewe, et al.
ACS Pharmacology & Translational Science|June 18, 2026
Interaction between Paracetamol Glucuronide and a Glucose-Sensitive Insulin Molecule (NNC2215): Increased Risk of HypoglycemiaJeppe Sturis, Lene Alifrangis, Peter K Nielsen, et al.
NPJ Digital Medicine|June 2, 2026
Human expertise or artificial intelligence? A prospective study on nail disorder diagnosisFlurin L Brand, Ali Mokhtari, Simone Cazzaniga, et al.
Diabetologia|November 20, 2022
Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse modelsHenning Hvid, Christian L Brand, Tina Hummelshøj, et al.
Nature|October 16, 2024
Glucose-sensitive insulin with attenuation of hypoglycaemiaThomas Hoeg-Jensen, Thomas Kruse, Christian L Brand, et al.
Plos Pathogens|December 9, 2024
A potent and selective reaction hijacking inhibitor of Plasmodium falciparum tyrosine tRNA synthetase exhibits single dose oral efficacy in vivoStanley C Xie, Chia-Wei Tai, Craig J Morton, et al.
Pageof 34